A new marine ecdysteroid with an α-hydroxy group attaching at C-4 instead of attaching at C-2 and C-3, named palythone A (1), together with eight known compounds (2-9) were obtained from the ethanolic extract of the Formosan zoanthid Palythoa mutuki. The structures of those compounds were mainly determined by NMR spectroscopic data analyses. The absolute configuration of 1 was further confirmed by comparing experimental and calculated circular dichroism (CD) spectra.
Introduction
Zoanthid of the genus Palythoa (family Sphenopidae) is a kind of benthos commonly found in shallow waters. More than 90 species of this genus were identified in subtropical and tropical areas all over the world. This marine creature is characterized by absorbing sands or small sediments into polyp to reinforce their structure. Apart from the well-known poisonous compound, palytoxin [1] , Palythoa zoanthids were also reported to produce various natural products, such as amino acids [2, 3] , steroids [4] , ecdysteroids [5] , prostanoids [6] , and sulfonylated ceramides [7] . The natural products of zoanthids not only act as defensive substance against predators, but also exhibit diverse bioactivities for the development of new drugs. For example, a polyhydroxylated steroid isolated from P. tuberculosa selectively inhibited human breast cancer cells (MCF-7), which implied this compound might be a new anti-cancer therapeutic agent [8] . Recently, our research group has studied anti-dengue virus ecdysteroids from Formosan zoanthid Zoanthus spp. [9] . In our continuous screening for bioactive marine natural products, the ethanolic extract of P. mutuki showed strong anti-dengue virus activity. Because there is no medicine for dengue fever, the animal materials of P. mutuki were investigated for its bioactive ingredients. In this manuscript, the isolation, structural elucidation, antiviral activity, and ChemGPS-NP space mapping analysis of one new and eight known compounds from P. mutuki are described.
Results and Discussion
The animal materials of P. mutuki were collected in the northeast coast of Taiwan. The sample was extracted by ethanol and partitioned between 75% methanol and hexanes to give two different organic extracts. Repeated column chromatography of the 75% methanol extract yielded one new compound, palythone A (1), and eight known compounds, 20-hydroxyecdysone 2-acetate (2) [10] , 3-deoxy-20-hydroxyecdysone (3) [11] , 24-epi-makisterone A (4) [12] , 20-hydroxyecdysone 3-acetate (5) [10] , 2-deoxyecdysterone (6) [13] , 20-hydroxyecdysone (7) [14] , α-ecdysone (8) [15] , and peridinin (9) [16] . The structures of all isolates were determined according to their spectroscopic data and are shown in Figure 1 . 
Introduction
Results and Discussion
The animal materials of P. mutuki were collected in the northeast coast of Taiwan. The sample was extracted by ethanol and partitioned between 75% methanol and hexanes to give two different organic extracts. Repeated column chromatography of the 75% methanol extract yielded one new compound, palythone A (1), and eight known compounds, 20-hydroxyecdysone 2-acetate (2) [10] , 3-deoxy-20-hydroxyecdysone (3) [11] , 24-epi-makisterone A (4) [12] , 20-hydroxyecdysone 3-acetate (5) [10] , 2-deoxyecdysterone (6) [13] , 20-hydroxyecdysone (7) [14] , α-ecdysone (8) [15] , and peridinin (9) [16] . The structures of all isolates were determined according to their spectroscopic data and are shown in Figure 1 . The stereochemistry of 1 was determined by the NOESY correlations ( Figure 3 ) and confirmed by the CD experiments. The cis-fused geometry of rings A and B were determined by means of the NOESY correlations between Me-19 and H-5 (δ 2.32). The hydroxy group attached at C-4 was placed on the α-face according to the presence of the NOESY correlation between H-4 and H-5 and the absence of NOESY correlation between H-4 and H-9. To confirm the absolute configuration of C-4, the ECD experiment was carried out. The experimental CD spectrum of 1 demonstrated two positive bands (231 and 306 nm) and two negative bands (209 and 259 nm), which resembled the calculated ECD spectra of 4R-1 ( Figure 4) . Thus, the absolute configuration of C-4 was defined to be R. The NOESY cross-peaks of Me-19/H-11β (δ 1.70)/Me-18 revealed that these protons are on the β-face of the molecule. On the other hand, the presence of NOESY correlations of H-9/H-11α (δ 1.80) and H-17/Me-21 indicated that these protons locate on the α-face. The R configurations of both C-20 and C-22 were determined by comparing proton chemical shifts of 1 with related ecdysteroids [17] . Therefore, structure of 1 was determined unambiguously.
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Optical rotation was measured on a JASCO P-1020 digital polarimeter (Tokyo, Japan). UV data were recorded on a JASCO V-530 UV/VIS Spectrophotometer (Tokyo, Japan). CD spectrum was acquired on a JASCO J-815 CD spectrometer (Tokyo, Japan). High-resolution ESIMS data were obtained on a Bruker APEX II spectrometer (Billerica, MA, USA). IR spectrum was measured on a Perkin Elmer system 2000 FT-IR spectrophotometer (Waltham, MA, USA). NMR spectra were obtained by Varian 600 MHz NMR (San Carlos, CA, USA). Merck silica gel 60 (Billerica, MA, USA) and Sephadex LH-20 (Stockholm, Sweden) were used for column chromatography. The instrumentation for HPLC was composed of a Shimadzu LC-10AD pump (Kyoto, Japan) and a Shimadzu SPD-M10A PDA detector (Kyoto, Japan).
Animal Material
Specimens of Palythoa mutuki were collected in Keelung City, Taiwan, in August 2015. The research samples were identified by its 16S rDNA gene sequence. A voucher specimen (no. KMU-MrPm) was deposited in the Graduate Institute of Natural Products, College of Pharmacy, Kaohsiung Medical University.
Species Identification
Samples were preserved in 75% ethanol at ambient temperature. DNA was extracted by a DNeasy Plant Mini Kit (Qiagen #68163, Venlo, The Netherlands). Two sets of primers 16Santa1a: 5 1 -GCCATGAGTATAGACGCACA-3 1 /16SbmoH: 5 1 -CGAACAGCCAACCCT TGG-3 1 and HCO2198:5 1 -TAAACTTCAGGGTGACCAAAAAATCA-3 1 /LCO1490: 5 1 -GGTCAACAAATCA TAAAGATA TTGG-3 1 were chosen to amplify the mitochondrial 16S (mt 16S), respectively. PCR amplifications were worked using FlexCycler 2 (analytik jena) (Jena, Germany) with the latter conditions: 94˝C (1 min), 40 cycles of 98˝C (10 s), 52˝C (1 min), and 68˝C (1 min), with the last extension at 68˝C (5 min). The purified PCR products were analyzed by Genomics BioSci & Tech. (New Taipei City, Taiwan) for sequencing services. The mt 16S rDNA gene sequence were compared with NCBI database. Consequently, the research sample shared 100% sequence identity with Palythoa mutuki (GenBank: DQ997847.1).
Extraction and Isolation
The animal material was extracted by ethanol three times and partitioned between ethyl acetate and water to give an ethyl acetate-soluble extract. This extract was further partitioned between hexanes and 75% methanol for separating low polar compounds. The 75% methanol-soluble extract (11.9 g) was subjected to a Sephadex LH-20 column (Stockholm, Sweden) eluted with methanol to give four fractions (L1-L4). Fraction L2 (1.7 g) was separated by a Si gel column eluted with methylene chloride and methanol (12:1 to 0:1) to furnish fourteen fractions (L2S1-L2S14). Fraction L2S7 (119.3 mg) was purified by HPLC (Luna phenyl-hexyl, 10 mmˆ250 mm, flow rate, 2.0 mL/min, 23% acetonitrile) to afford compounds 5 (33.8 mg) and 2 (49.5 mg). Fractions L2S8 (26.9 mg) was isolated by HPLC (Luna phenyl-hexyl, 10 mmˆ250 mm, flow rate = 2.0 mL/min, 23% acetonitrile) to yield compounds 1 (0.6 mg), 3 (0.8 mg) and 6 (4.1 mg). Fractions L2S9 (83.1 mg) was subjected to HPLC (Luna phenyl-hexyl, 10 mmˆ250 mm, flow rate = 2.0 mL/min, 20% acetonitrile) to give compound 4 (7.6 mg), 7 (0.4 mg), and 8 (1.0 mg). Fraction L3 (1.1 g) was separated by a Si gel column eluted with hexane, ethyl acetate, and methanol (15:1:0 to 0:0:1) to furnish ten fractions (L3S1-L3S10). Fractions L3S4 (90.6 mg) was isolated by HPLC (Luna C 18 , 10 mmˆ250 mm, flow rate = 2.0 mL/min, 85% methanol) to obtain compound 9 (1.5 mg). 
ECD Calculations
The minima energies of 4R-1 and 4S-1 were calculated by ChemBio3D (ver. 14.0, Perkin Elmer, Waltham, MA, USA) and the structure of 4R-1 and 4S-1 were saved as tinker MM2 input files. These data were imported into the Gaussian 09 for density functional theory (DFT) at the B3LYP/6-31G(d) level in the gas phase to obtain the restricted conformations. The energies, rotational strengths, and oscillator strengths of the 20 weakest conformers were optimized using the time-dependent density functional theory (TDDFT) methodology at the B3LYP/6-311++G(d,p) level. The final ECD files were converted to txt files by GaussSum 2.2.5 (Gaussian Inc., Wallingford, CT, USA) with a bandwidth σ of 0.5 eV. The ECD and CD curves were plotted by Excel.
Anti-DENV Activity Assay
Huh-7 cells were cultured in Dulbecco's modified Eagle's medium (DMEM) containing 10% fetal bovine serum, 1% non-essential amino acids, and 1% antibiotic-antimycotic in a 5% CO 2 at 37˝C. Huh-7 cells were seeded at 24-well plate at density 5ˆ10 4 cells/well and infected by DENV infection at a multiplicity of infection (MOI) of 0.2 followed by test compounds treatment 2 h post infection. Total cellular RNA were harvested at 72 h post-infection, and DENV RNA level was analyzed using quantitative real-time reverse-transcription polymerase chain reaction (qRT-PCR) with specific primers against DENV NS5 gene. DENV RNA level was normalized by cellular glyceraldehydes-3-phosphate dehydrogenase (gapdh) mRNA level. 2 1 -C-methylcytidine (2 1 CMC) served as positive control. DENV of different serotypes (DENV-1: DN8700828; DENV-2: DN454009A; DENV-3: DN8700829A; DENV-4: S9201818) were obtained from the Centers for Disease Control, Department of Health, Taipei, Taiwan.
Evaluation of Anti-DENV RdRp and Protease Activity
The DENV RdRp activity reporter system was used to determine the anti-DENV RdRp activity as described before [18] . The NS3 protease reporter-based assay was used to determine the anti-DENV protease activity. The Huh-7 cells were transfected with DENV NS2B/NS3 protease reporter vector pEG(∆4B/5)NLuc carrying a specific DENV protease cleavage peptide sequences and the DENV protease expression vector. Subsequently, the cells were treated with compound 9 for 3 days.
The supernatant was collected to analyze the nano luciferase (NLuc) activity by Nano-Glo ® Luciferase Assay System following the manufacturer's instructions (Promega, Madison, WI, USA).
Cytotoxicity Assay
Huh-7 cells were seeded onto 96-well plate at a density of 5ˆ10 3 cells per well, followed by compound treatment for 72 h. The cell viability was determined using a standard MTS assay (CellTiter 96 ® Aqueous One Solution Cell Proliferation assay system, Promega, Madison, WI, USA) according to the manufacturer's instructions.
ChemGPS-NP Analysis
Anti-dengue virus compounds were classified into three datasets (17 ecdysteroids, 8 limonoids, and 12 non-peptidic compounds), 2 positive control compounds, and peridinin. The structures of all compounds were converted to line notations (SMILES). The SMILES data were submitted to ChemGPS-NP web (http://chemgps.bmc.uu.se) for mapping chemical space. The results were plotted with 3D grapher 1.21 (RomanLab software, Vancouver, BC, Canada).
Conclusions
In our continuous investigation on discovering anti-dengue virus natural products, the Formosan zoanthid Palythoa mutuki has resulted in the identification of one new ecdysteroid (1) and eight known compounds (2-9). The potent anti-dengue virus activity of peridinin (9), a common secondary metabolite in marine invertebrates and dinoflagellates was discovered for the first time. Our findings suggest carotenoid-like substance might possess anti-dengue virus activity. Zoanthids have become one of the good resources for antiviral natural product development.
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